Viewing Study NCT01044069


Ignite Creation Date: 2025-12-24 @ 10:47 PM
Ignite Modification Date: 2025-12-30 @ 1:45 PM
Study NCT ID: NCT01044069
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-23
First Post: 2010-01-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module